VEGF-C MM0006-2E6-0.025 MG
|
VEGF-C, Host Species: Mouse, Target Species: Human, Monoclonal, Immunohistochemistry, Clone: MM0006-2E65, Primary, LYOPH, Unconjugated, 0.025 mg, Western Blot 1:1000, Immunohistochemistry 1:25-50, Immunohistochemistry-Paraffin 1:25-1:50, Pu
|
4797-NB110609710025MG
|
EA
|
|
VEGF 6D3-0.025 MG
|
VEGF, Host Species: Mouse, Target Species: Human, Monoclonal, Western Blot, Clone: 6D3, Primary, LYOPH, Unconjugated, 0.025 mg, Western Blot 2-10 ug/ml, ELISA 1-15 ug/ml, Blocking/Neutralizing 50-200 molar excess, Purified, PBS with No Pres
|
4797-NBP1186210025MG
|
EA
|
|
VEGF VG76E-0.025 MG
|
VEGF, Host Species: Rabbit, Target Species: Human, Mouse, Primate, Monoclonal, WB, ELISA, IHC, Clone: VG76e, Unconjugated, 0.025 mg, WB 1:100 - 1:2000, ELISA 1:100 - 1:2000, IHC 1:10 - 1:500, Purified, PBS
|
4797-NBP2625640025MG
|
EA
|
|
VEGF VG1-0.025 MG
|
VEGF, Host: Mouse, WB, Flow, ELISA, IHC, ICC, IF, IHC (P), IHC (F), CyTOF, Clone: VG1, Target Species: Human, Mouse, Rat, Porcine, Canine, Monoclonal, Primary, 1 mg/ml, Unconjugated, 0.025 mg, Novus Biologicals
|
4797-NB100664SS
|
EA
|
|
VEGF 165 BEVACIZU-0.025 MG
|
VEGF 165, Host Species: Rabbit, Target Species: Human, Monoclonal, WB, FC, ELISA, IP, Blocking Assay, Neutralization, Clone: Bevacizumab, Unconjugated, 0.025 mg, WB, FC, ELISA, IP, Block/Neutralize, Purified, PBS
|
4797-NBP2596380025MG
|
EA
|
|